The Prospective Segeberg TAVI Registry
Launched by SEGEBERGER KLINIKEN GMBH · Jun 18, 2017
Trial Information
Current as of May 29, 2025
Recruiting
Keywords
ClinConnect Summary
The Prospective Segeberg TAVI Registry is a clinical study taking place at the Heart Center in Bad Segeberg, Germany. This trial is focused on patients with aortic valve stenosis, a condition where the heart's aortic valve narrows, making it harder for the heart to pump blood. The study aims to gather information about patients who are treated with a procedure called Transcatheter Aortic Valve Implantation (TAVI), which is a minimally invasive way to replace the aortic valve.
Anyone aged 65 and older who is receiving TAVI treatment at this center can participate in the trial. There are no specific exclusions, meaning that almost all patients who undergo this treatment can join. If you participate, you can expect to be part of a registry that tracks your treatment and outcomes, helping doctors learn more about how effective TAVI is for patients like you. By joining this study, you will contribute to important research that could improve care for future patients with similar heart conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients treated with TAVI
- Exclusion Criteria:
- • None
About Segeberger Kliniken Gmbh
Segeberger Kliniken GmbH is a leading healthcare organization specializing in innovative clinical research and patient care. With a commitment to advancing medical science, the company conducts a range of clinical trials aimed at developing new therapies and improving treatment outcomes across various medical disciplines. Backed by a team of experienced professionals and state-of-the-art facilities, Segeberger Kliniken GmbH collaborates with academic institutions and industry partners to ensure the highest standards of clinical excellence and ethical practices. Their dedication to patient safety and scientific integrity positions them as a trusted sponsor in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bad Segeberg, , Germany
Patients applied
Trial Officials
Gert Richardt, MD
Study Chair
Heart Center, Segeberger Kliniken
Mohamed Abdel-Wahab, MD
Principal Investigator
Heart Center, Segeberger Kliniken
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials